Citation 80964

ITO,A: SHAMON,LS: YU,BY: MATA-GREENWOOD,E: LEE,SK: VAN BREEMEN,RB: METHA,RG: FARNSWORTH,NR: FONG HHS: PEZZUTO,JM: KINGHORN,AD:. (1998). ANTIMUTAGENIC CONSTITUENTS OF CASIMIROA EDULIS WITH POTENTIAL CANCER CHEMOPREVENTIVE ACTIVITY.. 46(9)

Citation Details

Title	ANTIMUTAGENIC CONSTITUENTS OF CASIMIROA EDULIS WITH POTENTIAL CANCER CHEMOPREVENTIVE ACTIVITY.
Authors	ITO,A: SHAMON,LS: YU,BY: MATA-GREENWOOD,E: LEE,SK: VAN BREEMEN,RB: METHA,RG: FARNSWORTH,NR: FONG HHS: PEZZUTO,JM: KINGHORN,AD:
Year	1998
Volume	46
Issue	9

Summary

Year: 1998

Journal: Unknown

Organisms and Their Experiments (1)

Casimiroa edulis (RUTACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	PHELLOPTERIN	None
2	ANTITUMOR ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	None	ACTIVE
3	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
4	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PHELLOPTERIN	ACTIVE
5	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PHELLOPTERIN	EQUIVOCAL
6	TUMOR NECROSING FACTOR SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHELLOPTERIN	ACTIVE
7	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PIMPINELLIN,ISO:	None
8	TUMOR NECROSING FACTOR SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PIMPINELLIN,ISO:	ACTIVE
9	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PIMPINELLIN,ISO:	ACTIVE
10	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PIMPINELLIN,ISO:	INACTIVE
11	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PSORALEN,5-METHOXY-8-[(6-7-DIHYDROXY-3-7-DIMETHYL-2-OCTENYL)-OXY]: (R-S):	None
12	TUMOR NECROSING FACTOR SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PSORALEN,5-METHOXY-8-[(6-7-DIHYDROXY-3-7-DIMETHYL-2-OCTENYL)-OXY]: (R-S):	INACTIVE
13	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PSORALEN,5-METHOXY-8-[(6-7-DIHYDROXY-3-7-DIMETHYL-2-OCTENYL)-OXY]: (R-S):	ACTIVE
14	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PSORALEN,5-METHOXY-8-[(6-7-DIHYDROXY-3-7-DIMETHYL-2-OCTENYL)-OXY]: (R-S):	WEAK ACTIVITY
15	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PSORALEN,8-[(6-7-DIHYDROXY-3-7-DIMETHYL-2-OCTENYL)-OXY]: (R-S):	None
16	TUMOR NECROSING FACTOR SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PSORALEN,8-[(6-7-DIHYDROXY-3-7-DIMETHYL-2-OCTENYL)-OXY]: (R-S):	INACTIVE
17	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PSORALEN,8-[(6-7-DIHYDROXY-3-7-DIMETHYL-2-OCTENYL)-OXY]: (R-S):	ACTIVE
18	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PSORALEN,8-[(6-7-DIHYDROXY-3-7-DIMETHYL-2-OCTENYL)-OXY]: (R-S):	WEAK ACTIVITY
19	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	CASIMIROIN	None
20	TUMOR NECROSING FACTOR SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CASIMIROIN	INACTIVE
21	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CASIMIROIN	ACTIVE
22	CELL DIFFERENTIATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CASIMIROIN	INACTIVE
23	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CASIMIROIN	ACTIVE
24	Not specified	ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA	QUINOLINONE,2(1-H): 1-METHYL: 4-METHOXY:	None
25	TUMOR NECROSING FACTOR SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINOLINONE,2(1-H): 1-METHYL: 4-METHOXY:	INACTIVE
26	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINOLINONE,2(1-H): 1-METHYL: 4-METHOXY:	ACTIVE
27	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	QUINOLINONE,2(1-H): 1-METHYL: 4-METHOXY:	WEAK ACTIVITY
28	Not specified	ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA	QUINOL-4-ONE,1-METHYL: 5-HYDROXY-2-PHENYL:	None
29	EROD INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINOL-4-ONE,1-METHYL: 5-HYDROXY-2-PHENYL:	WEAK ACTIVITY
30	MUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINOL-4-ONE,1-METHYL: 5-HYDROXY-2-PHENYL:	ACTIVE
31	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	QUINOL-4-ONE,1-METHYL: 5-HYDROXY-2-PHENYL:	WEAK ACTIVITY
32	Not specified	ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA	FAGARINE,GAMMA:	None
33	Not specified	ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA	ZAPOTIN	None
34	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ZAPOTIN	INACTIVE
35	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ZAPOTIN	ACTIVE
36	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FLAVONE,2'-5-6-TRIMETHOXY:	None
37	EROD INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,2'-5-6-TRIMETHOXY:	ACTIVE
38	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,2'-5-6-TRIMETHOXY:	ACTIVE
39	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,2'-5-6-TRIMETHOXY:	ACTIVE
40	CELL DIFFERENTIATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,2'-5-6-TRIMETHOXY:	ACTIVE
41	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVONE,2'-5-6-TRIMETHOXY:	ACTIVE
42	EROD INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,2'-5-6-TRIMETHOXY:	ACTIVE

Citation 80964

Citation Details

Summary

Organisms and Their Experiments (1)

Casimiroa edulis (RUTACEAE)

Show SPARQL Queries (1)

Query 1